| Literature DB >> 30217168 |
Clarence C Tam1,2, Vittoria Offeddu3, Kathryn B Anderson4,5, Alden L Weg5, Louis R Macareo5, Damon W Ellison5, Ram Rangsin6, Stefan Fernandez5, Robert V Gibbons7, In-Kyu Yoon8, Sriluck Simasathien9.
Abstract
BACKGROUND: Multiplex real-time polymerase chain reaction assays have improved diagnostic sensitivity for a wide range of pathogens. However, co-detection of multiple agents and bacterial colonization make it difficult to distinguish between asymptomatic infection or illness aetiology. We assessed whether semi-quantitative microbial load data can differentiate between symptomatic and asymptomatic states for common respiratory pathogens.Entities:
Keywords: Asymptomatic infection; Haemophilus influenza; Influenza; Influenza-like illness; Multiplex PCR diagnostics; Respiratory illness; Upper respiratory tract infection
Mesh:
Substances:
Year: 2018 PMID: 30217168 PMCID: PMC6137728 DOI: 10.1186/s12879-018-3358-4
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Median cycle threshold (Ct) values and interquartile range (IQR) for microbes identified in throat and nasal swab samples. Non-acute samples were collected from Royal Thai Army barracks trainees at the start (R0) and at the end (RF) of each 10-week training period. Acute samples were collected from trainees who developed acute upper respiratory tract infection during follow-up. Percentages indicate the proportion of collected samples positive for each organism
| Non-acute ( | Acute ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| R0 ( | RF ( | |||||||||
| % (n) | Median Ct | IQR | % (n) | Median Ct | IQR | % (n) | Median Ct | IQR | ||
| Bacteria | ||||||||||
| | 83.8 (176) | 28.3 | 26.5–29.6 | 65.7 (67) | 29.7 | 28.6–31.4 | 64.8 (94) | 29.4 | 28.0–31.3 | 0.297 |
| | 31.9 (67) | 30.2 | 28.4–31.1 | 73.5 (75) | 24.9 | 22.1–27.1 | 56.6 (82) | 26.7 | 22.0–29.0 | < 0.001 |
| | 8.1 (17) | 29.6 | 27.7–30.7 | 34.3 (35) | 28.0 | 26.1–31.0 | 15.2 (22) | 27.1 | 26.5–29.2 | 0.706 |
| | 14.3 (30) | 31.2 | 28.3–32.7 | 9.8 (10) | 29.0 | 26.8–32.0 | 15.9 (23) | 31.4 | 29.7–32.3 | 0.706 |
| | 10.5 (22) | 31.3 | 30.4–32.5 | 9.8 (10) | 31.4 | 31.1–32.2 | 6.2 (9) | 31.1 | 30.6–31.6 | 0.739 |
| | 2.4 (5) | 30.6 | 27.7–31.5 | 3.9 (4) | 32.6 | 32.2–32.8 | 6.2 (9) | 29.7 | 29.5–31.5 | 0.564 |
| | 2.4 (5) | 32.1 | 31.4–32.4 | 2.0 (2) | 31.3 | 30.3–32.4 | 2.8 (4) | 32.5 | 31.2–32.8 | 0.317 |
| Viruses | ||||||||||
| Rhinovirus | 1.9 (4) | 30.6 | 28.6–31.8 | 15.7 (16) | 30.2 | 27.2–31.7 | 26.9 (39) | 28.9 | 26.9–31.4 | < 0.001 |
| Adenovirus | 0.5 (1) | 27.2 | 27.2–27.2 | 9.8 (10) | 30.5 | 29.6–31.4 | 2.8 (4) | 29.3 | 27.0–31.0 | 0.083 |
| Influenza B | 0 (0) | – | – | 0 (0) | – | – | 9.7 (14) | 25.4 | 23.6–31.2 | – |
| Coronavirus 229 | 1 (2) | 23.1 | 18.2–28.0 | 2.0 (2) | 29.3 | 27.2–31.5 | 4.8 (7) | 26.9 | 25.2–31.3 | 0.034 |
| Enterovirus | 0.5 (1) | 30.7 | 30.7–30.7 | 4.9 (5) | 30.2 | 30.1–30.3 | 0 (0) | – | – | – |
| Coronavirus 63 | 1 (2) | 28.5 | 24.5–32.4 | 1.0 (1) | 30.0 | 30.0–30.0 | 1.4 (2) | 22.6 | 21.9–23.3 | 0.157 |
| Coronavirus HKU | 0.5 (1) | 30.0 | 30.0–30.0 | 0 (0) | – | – | 2.1 (3) | 32.2 | 31.6–32.9 | – |
| Parainfluenza 2 | 0.5 (1) | 17.4 | 17.4–17.4 | 1.0 (1) | 25.3 | 25.3–25.3 | 1.4 (2) | 23.3 | 20.1–26.5 | 0.564 |
| Parainfluenza 4 | 0.5 (1) | 32.0 | 32.0–32.0 | 0 (0) | – | – | 1.4 (2) | 30.3 | 30.0–30.6 | 0.317 |
| Coronavirus 43 | 0.5 (1) | 28.1 | 28.1–28.1 | 0 (0) | – | – | 0.7 (1) | 32.6 | 32.6–32.6 | – |
| Bocavirus | 0.5 (1) | 17.4 | 17.4–17.4 | 0 (0) | – | – | 0 (0) | – | – | – |
| Influenza A | 0 (0) | – | – | 0 (0) | – | – | 0.7 (1) | 29.9 | 29.9–29.9 | – |
ap-value for difference in proportion of positive samples in non-acute samples collected at the start (R0) of the training period or acute samples from individuals who developed URI during follow-up, as computed by McNemar test
Frequency of single and multiple infections. Non-acute specimens were collected at the start (R0) or end (RF) of the training period. Acute samples were collected from individuals who developed an acute upper respiratory tract infection during follow-up. Percentages indicate proportion of specimens in which no microbe, a single, or multiple microbes were detected
| Non-acute | Acute | Total | ||
|---|---|---|---|---|
| R0 ( | RF ( | ( | ( | |
| Negative for all microbes | 5.2% (11) | 6.9% (7) | 4.1% (6) | 5.3% (24) |
| 1 microbe detected | 47.6% (100) | 15.7% (16) | 24.1% (35) | 33.0% (151) |
| > 1 microbe detected | 47.1% (99) | 77.5% (79) | 71.7% (104) | 61.7% (282) |
Frequency of co-detections with selected organism pairs among acute samples. Acute specimens were collected from individuals who developed upper respiratory tract infection during follow-up (n = 145)
| Microbe 1 | %(n) detecteda | Microbe 2 | %(n) detecteda | %(n) co-detectedb | |
|---|---|---|---|---|---|
|
| 64.8 (94) |
| 56.6 (82) | 32.4 (47) | 0.031 |
|
| 64.8 (94) | Rhinovirus | 26.9 (39) | 22.1 (32) | 0.008 |
| Influenza B | 9.7 (14) |
| 56.6 (82) | 8.3 (12) | 0.024* |
|
| 64.8 (94) |
| 15.2 (22) | 4.1 (6) | < 0.001 |
|
| 6.2 (9) | Rhinovirus | 26.9 (39) | 4.1 (6) | 0.012* |
|
| 15.2 (22) | Influenza B | 9.7 (14) | 3.4 (5) | 0.04* |
|
| 64.8 (94) | Influenza B | 9.7 (14) | 2.1 (3) | 0.001* |
|
| 15.2 (22) | Parainfluenza 2 | 1.4 (2) | 1.4 (2) | 0.022* |
|
| 6.2 (9) | Human adenovirus | 2.8 (4) | 1.4 (2) | 0.019* |
aPercentages indicate proportion of acute samples where each microbe was identified
bPercentages indicate proportion of acute samples where each microbe pair was co-detected
cp-value computed by χ2- or Fisher’s exact (*) test, indicating that co-detection of each of the listed microbe pairs occurred more frequently than expected by chance
Fig. 1Pairwise probabilities of co-detection of bacterial and viral agents. Probabilities indicate the percentage of non-acute baseline (orange shading; n = 210) or acute samples (blue shading; n = 145) positive with each microbe pair. Bar charts on the upper or right hand side indicate number of non-acute baseline or acute samples positive for each microbe, respectively. Dark box outlines indicate microbe pairs detected more frequently than expected by chance, as assessed by χ2- or Fisher’s exact test (see also Table 3)
Fig. 2Cycle threshold value distribution in non-acute and acute samples. Ct-value distribution for selected a bacteria and b viruses detected in non-acute samples collected at the start or end of the training period (orange bars) or acute samples from individuals experiencing an upper respiratory tract infection during follow-up (blue bars). A Ct-value of < 33 was considered a positive result
Fig. 3Cycle threshold value distribution in samples containing one or multiple microbes. Ct-value distributions for selected bacteria detected in non-acute samples collected at the start or end of the training period (orange bars) and acute samples (blue bars) containing a single or multiple microbes. A Ct-value of < 33 was considered a positive result
Tobit regression analysis. Tobit regression model assessing differences in Ct-value distributions in non-acute samples collected at the start (R0) or end (RF) of the training period and acute samples collected from symptomatic individuals during follow-up. Acute samples are used as a reference
| Bacteria | Sample type | Coefficient | 95%CI | |
|---|---|---|---|---|
|
| R0 | −2.22 | −2.94; −1.49 | < 0.001 |
| RF | 0.11 | −0.80; 1.02 | 0.809 | |
|
| R0 | 5.56 | 4.05; 7.08 | < 0.001 |
| RF | −2.95 | −4.62; −1.27 | 0.001 | |
|
| R0 | 3.04 | 0.41; 5.67 | 0.024 |
| RF | −4.28 | −7.00; −1.56 | 0.002 | |
|
| R0 | 0.52 | −1.01; 2.05 | 0.506 |
| RF | 1.45 | −0.55; 3.45 | 0.155 | |
|
| R0 | −0.98 | −2.43; 0.47 | 0.186 |
| RF | −0.74 | −2.47; 0.99 | 0.401 | |
| Viruses | ||||
| Rhinovirus | R0 | 10.04 | 6.49; 13.58 | < 0.001 |
| RF | 2.83 | 0.39; 5.27 | 0.023 | |